Navigation Links
Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
Date:12/7/2010

When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.

In the case of agricultural areas, excreted antibiotics can then enter stream and river environments through a variety of ways, including discharges from animal feeding operations, fish hatcheries, and nonpoint sources such as the flow from fields where manure or biosolids have been applied. Water filtered through wastewater treatment plants may also contain used antibiotics.

Consequently, these discharges become "potential sources of antibiotic resistance genes," says Amy Pruden, a National Science Foundation CAREER Award recipient, and an assistant professor of civil and environmental engineering at Virginia Tech. http://www.cee.vt.edu/index.php?do=view&content=0&apps=2&level=2&id=17&pid=ea764b3d7ce4e619692fc864f6a5d628

"The presence of antibiotics, even at sub-inhibitory concentrations, can stimulate bacterial metabolism and thus contribute to the selection and maintenance of antibiotic resistance genes," Pruden explains. "Once they are present in rivers, antibiotic resistance genes are capable of being transferred among bacteria, including pathogens, through horizontal gene transfer."

The World Health Organization and the Center for Disease Control recognize antibiotic resistance "as a critical health challenge of our time," Pruden writes in a paper published in a 2010 issue of Environmental Science and Technology.

Pruden says reducing the spread of antibiotic resistance is a critical measure needed to prolong the effectiveness of currently available antibiotics. This is important since "new drug discovery can no longer keep pace with emerging antibiotic-resistant infections," Pruden says.

Pruden who has developed the concept of antibiotic resistance genes as environmental pollutants has an international reputation in applied microbial ecology, environmental remediation, and environmental reservoirs of antimicrobial resistance.

In her work outlined in the Environmental Science and Technology article, she and her co-authors, H. Storteboom, M. Arabi and J.G. Davis, all of Colorado State University, and B. Crimi of Delft University in The Netherlands, identified specific patterns of antibiotic resistance gene occurrence in a Colorado watershed. Identification of these patterns represents a major step in being able to discriminate between agricultural and wastewater treatment plant sources of these genes in river environments.

They assert that such unique patterns of antibiotic resistance gene occurrence represent promising molecular signatures that may then be used as tracers of specific manmade sources.

In their study they identified three wastewater treatment plant sites, six animal feeding operation locations, and three additional locations along a pristine region of the Poudre River, in an upstream section located in the Rocky Mountains. They compared the frequency of detection of 11 sulfonamide and tetracycline antibiotic resistance genes.

Their findings showed detection of one particular antibiotic resistance gene in 100 percent of the treatment plant and animal feeding operations, but only once in the clean section of the Poudre River.

As they are able to differentiate between human and animal sources of the antibiotic resistance genes, Pruden and her colleagues believe they can "shed light on areas where intervention can be most effective in helping to reduce the spread of these contaminants through environmental matrixes such as soils, groundwater, surface water and sediments.

"This study advances the recognition of antibiotic resistance genes as sources to impacted environments, taking an important step in the identification of the dominant processes of the spreading and transport of antibiotic resistance genes."


'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Related biology news :

1. Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study
2. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
3. Virginia Tech graduate student receives first Rachel Carson award for scientific excellence
4. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
5. Virginia Tech biomedical engineering team to study knee ligament sprains
6. Advances in cancer detection research by Virginia Tech engineer featured in British magazine
7. Virginia Tech licenses GenoCAD source code to ISCB
8. Guggenheim fellowship supports research on evolution by Virginia Tech scientist
9. Student research team sequences genome of bacterium discovered in Virginia Tech garden
10. Northrop Grumman Selects Virginia for New Corporate Office
11. Virginia Tech researcher explores role of human behavior in infectious disease emergence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017  VWR Corporation (NASDAQ: VWR), the leading global ... production customers, today reported its financial results for the fourth ... Highlights: 4Q16 record quarterly net sales ... an organic basis. 4Q16 EMEA-APAC ... basis, while the Americas net sales increased 2.5%, or down ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
Breaking Biology Technology: